These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 1718434

  • 21. Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini.
    Sankaran H, Goldfine ID, Deveney CW, Wong KY, Williams JA.
    J Biol Chem; 1980 Mar 10; 255(5):1849-53. PubMed ID: 6243650
    [Abstract] [Full Text] [Related]

  • 22. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
    Talkad VD, Patto RJ, Metz DC, Turner RJ, Fortune KP, Bhat ST, Gardner JD.
    Biochim Biophys Acta; 1994 Oct 20; 1224(1):103-16. PubMed ID: 7524683
    [Abstract] [Full Text] [Related]

  • 23. Receptor binding of cholecystokinin analogues in isolated rat pancreatic acini.
    Doi R, Hosotani R, Inoue K, Fujii N, Yajima H, Rayford PL, Tobe T.
    Biochem Biophys Res Commun; 1990 Jan 15; 166(1):286-92. PubMed ID: 2302208
    [Abstract] [Full Text] [Related]

  • 24. Biochemical regulation of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
    Pandya PK, Huang SC, Talkad VD, Wank SA, Gardner JD.
    Biochim Biophys Acta; 1994 Oct 20; 1224(1):117-26. PubMed ID: 7948036
    [Abstract] [Full Text] [Related]

  • 25. Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists.
    Spanarkel M, Martinez J, Briet C, Jensen RT, Gardner JD.
    J Biol Chem; 1983 Jun 10; 258(11):6746-9. PubMed ID: 6304053
    [Abstract] [Full Text] [Related]

  • 26. Modulation of cholecystokinin activity by albumin.
    Huang SC, Talkad VD, Fortune KP, Jonnalagadda S, Severi C, Delle Fave G, Gardner JD.
    Proc Natl Acad Sci U S A; 1995 Oct 24; 92(22):10312-6. PubMed ID: 7479774
    [Abstract] [Full Text] [Related]

  • 27. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC, Zhang L, Chiang HC, Wank SA, Maton PN, Gardner JD, Jensen RT.
    Am J Physiol; 1989 Jul 24; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [Abstract] [Full Text] [Related]

  • 28. Prostaglandin E2 inhibits secretagogue-induced enzyme secretion from rat pancreatic acini.
    Mössner J, Secknus R, Spiekermann GM, Sommer C, Biernat M, Bahnsen H, Fischbach W.
    Am J Physiol; 1991 May 24; 260(5 Pt 1):G711-9. PubMed ID: 1709788
    [Abstract] [Full Text] [Related]

  • 29. Functional and molecular characterization of CCK receptors in the rat pancreatic acinar cell line AR 4-2J.
    Lambert M, Diem Bui N, Christophe J.
    Regul Pept; 1991 Feb 01; 32(2):151-67. PubMed ID: 1709748
    [Abstract] [Full Text] [Related]

  • 30. Rottlerin inhibits stimulated enzymatic secretion and several intracellular signaling transduction pathways in pancreatic acinar cells by a non-PKC-delta-dependent mechanism.
    Tapia JA, Jensen RT, García-Marín LJ.
    Biochim Biophys Acta; 2006 Jan 01; 1763(1):25-38. PubMed ID: 16364465
    [Abstract] [Full Text] [Related]

  • 31. Down-regulation and recycling of high affinity cholecystokinin receptors on pancreatic acinar cells.
    Menozzi D, Vinayek R, Jensen RT, Gardner JD.
    J Biol Chem; 1991 Jun 05; 266(16):10385-91. PubMed ID: 2037588
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Internalization-sequestration and degradation of cholecystokinin (CCK) in tumoral rat pancreatic AR 4-2 J cells.
    Svoboda M, Dupuche MH, Lambert M, Bui D, Christophe J.
    Biochim Biophys Acta; 1990 Dec 10; 1055(3):207-16. PubMed ID: 2265208
    [Abstract] [Full Text] [Related]

  • 35. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini.
    Akiyama T, Tachibana I, Otsuki M.
    Int J Pancreatol; 1993 Oct 10; 14(2):167-73. PubMed ID: 7506744
    [Abstract] [Full Text] [Related]

  • 36. Characterization of a new cholecystokinin receptor antagonist FK480 in in vitro isolated rat pancreatic acini.
    Akiyama T, Otsuki M.
    Pancreas; 1994 May 10; 9(3):324-31. PubMed ID: 8022754
    [Abstract] [Full Text] [Related]

  • 37. High-affinity cholecystokinin type A receptor/cytosolic phospholipase A2 pathways mediate Ca2+ oscillations via a positive feedback regulation by calmodulin kinase in pancreatic acini.
    Lankisch TO, Nozu F, Owyang C, Tsunoda Y.
    Eur J Cell Biol; 1999 Sep 10; 78(9):632-41. PubMed ID: 10535305
    [Abstract] [Full Text] [Related]

  • 38. Temperature dependence of high-affinity CCK receptor binding and CCK internalization in rat pancreatic acini.
    Williams JA, Bailey AC, Roach E.
    Am J Physiol; 1988 Apr 10; 254(4 Pt 1):G513-21. PubMed ID: 3354673
    [Abstract] [Full Text] [Related]

  • 39. A synthetic peptide derivative that is a cholecystokinin receptor antagonist.
    Lignon MF, Galas MC, Rodriguez M, Laur J, Aumelas A, Martinez J.
    J Biol Chem; 1987 May 25; 262(15):7226-31. PubMed ID: 2438274
    [Abstract] [Full Text] [Related]

  • 40. Differential expression of A- and B-subtypes of cholecystokinin/gastrin receptors in the developing calf pancreas.
    Le Meuth V, Philouze-Rome V, Le Huerou-Luron I, Formal M, Vaysse N, Gespach C, Guilloteau P, Fourmy D.
    Endocrinology; 1993 Sep 25; 133(3):1182-91. PubMed ID: 8365360
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.